Autoimmune hemolytic anemia in an infant with giant cell hepatitis.
Autoimmune hemolytic anemia (AIHA) associated with giant cell hepatitis (GCH) is a rare disorder in infants. AIHA usually precedes the development of liver disease by months to years. Early recognition of the disease and prompt institution of immunosuppressive therapy results in clinical remission and prevents liver disease progression.
Kashyap
Rajesh
R
Department of Hematology, All India Institute of Medical Sciences, New Delhi, India. rajkashyapmd@yahoo.co.in
Sarangi
J N
JN
Choudhry
V P
VP
D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D015726:Giant Cells / Q000473:pathology*; D005938:Glucocorticoids / Q000008:administration & dosage; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007155:Immunologic Factors / Q000008:administration & dosage; D007223:Infant; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D014580:Ursodeoxycholic Acid; D011241:Prednisone